Key facts
- It has raised $83.0M across 4 recorded rounds; the latest was Later Stage VC (Series B) ($45.0M) in Sep 2024.
- Notable investors include Astir Ventures, Spark Capital, Trousdale Ventures, Primary Venture Partners, Kishore Ganji — 18 tracked in total.
- Helaina has filed 3 Form Ds with the SEC since 2019, most recently Aug 2020 ($4.0M sold to 6 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Helaina
Funding rounds
4 roundsAbout Helaina
Producer of milk-equivalent baby formula intended to offer breast milk alternatives. The company produces bioactive proteins through fermentation to offer a new category of functional food products with immune benefits and nutritional options closest to breast milk, providing infants with an alternative that brings the immune-nourishing proteins of breast milk.
- Industry
- Other Consumer Non-Durables
- Sector
- Consumer Products and Services (B2C)
- HQ
- New York, NY, United States
- Founded
- 2019
- Employees
- 49
- Website
- myhelaina.com/
- Ownership
- Privately Held (backing)
Helaina doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Helaina shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Helaina in its N-PORT filings yet. We sweep new filings monthly.